Literature DB >> 2582412

Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans.

A J Wieczorek, C Rhyner, L H Block.   

Abstract

An RNA-proteolipid complex was isolated from sera of patients with a variety of malignant disorders as well as from culture media of malignant cell lines. The complex, characterized by a relatively constant composition, contains 27S poly(A)+ RNA and Mr 1250 oligopeptide(s) and is rich in phospholipids and glycosphingolipids. Serum lipoproteins (low and high density) differ from this complex in density, chemical composition, and immunological reactivity. The complex was detected in 94 of 96 cases of malignancy tested but not in any of 58 patients with nonmalignant disorders or in 46 healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582412      PMCID: PMC397794          DOI: 10.1073/pnas.82.10.3455

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  Separation of plasma lipoproteins by density-gradient ultracentrifugation.

Authors:  T G Redgrave; D C Roberts; C E West
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

3.  The effects of polyamines on a residue-specific human plasma ribonuclease.

Authors:  M Schmukler; P B Jewett; C C Levy
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

4.  Analytical studies on nuclear ribonucleic acid using polyacrylamide gel electrophoresis.

Authors:  C W Dingman; A C Peacock
Journal:  Biochemistry       Date:  1968-02       Impact factor: 3.162

5.  Effects of cancer upon high-density and other lipoproteins.

Authors:  M Barclay; V P Skipski; O Terebus-Kekish; E M Greene; R J Kaufman; C C Stock
Journal:  Cancer Res       Date:  1970-09       Impact factor: 12.701

6.  Actin microfilaments and fibroin secretion in the silkgland cells of Bombyx mori. Effects of cytochalasin B.

Authors:  P Couble; N Blaes; J C Prudhomme
Journal:  Exp Cell Res       Date:  1984-04       Impact factor: 3.905

7.  Fractionation and characterization of rat liver poly(A)-containing RNA.

Authors:  J Dennis; R Kisilevsky
Journal:  Biochim Biophys Acta       Date:  1979-02-27

8.  Plasma lipid alterations in leukemia and lymphoma.

Authors:  R J Spiegel; E J Schaefer; I T Magrath; B K Edwards
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

9.  Quantitative determination of the neutral glycosyl ceramides in human blood.

Authors:  D E Vance; C C Sweeley
Journal:  J Lipid Res       Date:  1967-11       Impact factor: 5.922

10.  Plasma cell immunoglobulin secretion: arrest is accompanied by alterations of the golgi complex.

Authors:  A M Tartakoff; P Vassalli
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  16 in total

1.  RNAs in the sera of Persian Gulf War veterans have segments homologous to chromosome 22q11.2.

Authors:  H B Urnovitz; J J Tuite; J M Higashida; W H Murphy
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Role of extracellular RNA in atherosclerotic plaque formation in mice.

Authors:  Sakine Simsekyilmaz; Hector A Cabrera-Fuentes; Svenja Meiler; Sawa Kostin; Yvonne Baumer; Elisa A Liehn; Christian Weber; William A Boisvert; Klaus T Preissner; Alma Zernecke
Journal:  Circulation       Date:  2013-11-07       Impact factor: 29.690

3.  Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.

Authors:  Akemi Sato; Naoko Sueoka-Aragane; Juichi Saitoh; Kazutoshi Komiya; Takashi Hisatomi; Rika Tomimasu; Shinichiro Hayashi; Eisaburo Sueoka
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-07       Impact factor: 4.553

4.  Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells.

Authors:  J M Silva; R Rodriguez; J M Garcia; C Muñoz; J Silva; G Dominguez; M Provencio; P España; F Bonilla
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  Proton NMR examination of tumor cells of high or low metastatic potential.

Authors:  S D Bines; S P Tomasovic; J W Frazer; J Leveque; A W Boddie; L Dennis
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

6.  Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Authors:  Christian Kannemeier; Aya Shibamiya; Fumie Nakazawa; Heidi Trusheim; Clemens Ruppert; Philipp Markart; Yutong Song; Eleni Tzima; Elisabeth Kennerknecht; Michael Niepmann; Marie-Luise von Bruehl; Daniel Sedding; Steffen Massberg; Andreas Günther; Bernd Engelmann; Klaus T Preissner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

7.  Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.

Authors:  Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

Review 8.  Emerging biological functions of ribonuclease 1 and angiogenin.

Authors:  Emily R Garnett; Ronald T Raines
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-12-09       Impact factor: 8.697

9.  Plasma LUNX mRNA, a non-invasive specific biomarker for diagnosis and prognostic prediction of non-small cell lung cancer.

Authors:  Hong-Xing Zhou; Ming-Xia Yang; Yan Wang; Wen-Ming Cao; Ke-Feng Lu; Ling-Yan Zong; Rong-Qiang Wu; Ping Zhang
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 10.  Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.

Authors:  Masahiro Tsujiura; Daisuke Ichikawa; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.